Clinical Approach to Renal, Bladder, Penile, Testicular & Prostate Cancer -Testicular Cancer Flashcards
RCCA Epi
- 50-60s YO
- 2X M>F
- Hispanic > White = Black
RCCA clinical triad
- Gross Hematuria
- Flank Pain
- Palpable Mass
PNPS related to RCCA
- Cushings’s Syndrome
- Protein enteropathy/ Enteroglucagon
- Prolactinemia
- Insulinemia
- Gonadotropinemia
RCCA Staging
Stage I: <7 cm
Stage II: >7 cm
Stage III: contained in Gerota’s Fascia; spread via IVC
Stage IV: Spread to other organs + LNs
Prostate CA EPI
- > 40 YO
- Black > White > Japanese
PSA Test
Normal 0-4 ng/ml
“gray zone” 4-10
Who should get PSA screening?
55-69 YO w/ average risk + asymptomatic
*Not recommended for 70 YO or more w/ LE less thatn 10 yrs
2017 AUA Guidelines
Very Low/Low: Gleason 1; PSA < 10
Intermediate: Gleason 7/Stage 2b; PSA 10-20
High Risk: Gleason >8; PSA > 20
Management of advanced metastatic cancer
- Orchiectomy
- LH-RH Agonist
- Gn-RH Antagonist
- Antiandrogens
Asymptomatic ptsd w/ PCA no longer responding to hormone Tx
Provenge
Castration-resistant PCA Tx
Zytiga with presnisone
Or
Taxotere
Testicular Cancer ETI
- Undescended testes/Cryptorchidism
- Exogenous estrogen administration to mother during pregnancy
- trauma + Infx
Testicular CA S/S
- painless enlargement
- acute testicular pain (rare)
- S/S of metastatic disease (rare)
- gynecomastia
Testicular tumor workup
- Biochem markers (AFP, hCG, LDH)
- Scrotal US
- CT to assess metastasis
- inguinal orchiectomy
Scrotal CA Tx
- Radical Orchiectomy
- Low-stage Seminoma -> Irradiation
- High stage Seminoma -> ChemoTx
- Low stage NSGCT -> RPLND or surveillance
- High-stage NSGCT -> ChemoTx; resection of residual mass